Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Risk of Clonal Hematopoiesis from Autologous Gene Therapies (and Baseline)

Coleman Lindsley, MD, PhD. Dana Farber Cancer Institute, Boston, MA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.